Search for Clinical Trial Results
Kennedy Disease - 25 Studies Found
Status | Study |
Terminated |
Study Name: GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer Condition:
|
Recruiting |
Study Name: A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF Condition: Prostate Cancer Date: 2015-03-27 Interventions:
|
Recruiting |
Study Name: Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC) Condition: Triple Negative Breast Cancer Date: 2015-02-10 Interventions: Drug: GTx-024 GTx-024 softgel capsules will be administered once-daily to a total dose of 18 mg |
Suspended |
Study Name: Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer Condition:
|
Recruiting |
Study Name: Phase IIB Neoadjuvant Enzalutamide (ZT) Plus Taxol for Androgen Receptor (AR)-Positive Triple-Negative Breast Cancer (AR+ TNBC) Condition: Breast Cancer Date: 2016-02-12 Interventions:
|